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Intellectual disabilityAbstract Few studies have looked at the incidence of complications performed with IV sedation
for dental treatment. The purposes of this study were to (1) delineate the nature and frequency
of postdental treatment complications associated with dental treatment under IV sedation in
individuals with intellectual disability, and (2) correlate morbidity reports with patient’s gender,
age, and duration of dental procedures.
Materials and methods: 28 Patients with intellectual disability, 13 females and 15 males, aged
3–36 years. IV Propofol was given 1 mg/kg IV Propofol bolus Incremental top ups of 0.25 mg/kg
Propofol as required. If the patients were dental treated, then postcomplications while recovering
in hospital were evaluated. Statistical comparisons of patient complications, gender, age, and
duration of dental treatment were made.
Results: There were no reported serious adverse effects. Minor posttreatment complications
occurred in 7 (25%), agitation in 28.6%, sleepiness in 28.6%, drowsiness in 14.3%, and pain in
14.3%, followed by dental bleeding in 14.3%. Gender of the patients was found to be signiﬁcantly
related to post-operative complications, while age and duration of dental treatment showed no
signiﬁcant relationship.
Conclusion: IV sedation with Propofol for patients with intellectual disability for dental treatment
appears to be with minor complications.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.1. Introduction
Persons with intellectual disability have difﬁculty in cooperat-
ing, so they need special support in order to receive dental
treatment, as many of them are referred for IV sedation [1].There are many drugs for IV sedation as Propofol. Propofol
alone or in combination with other sedatives/analgesics has
become popular for procedural sedation. Most published
guidelines do not include considerations for people with spe-
cial needs. There is a need for increased research and documen-
tation of combined treatment modalities, and these combined
approaches need to be incorporated into guidelines for patient
care for people with special needs [2].
The important goals of sedation/anesthesia for outpatient
surgery are low incidence of postoperative side effects
permitting a rapid and safe discharge [3].
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ment. Few studies have looked at the incidence of complica-
tions performed with IV sedation for dental treatment. So
the design is made to determine these complications and
their correlation to gender, age and duration of dental treat-
ment for the individuals with intellectual disability undergoing
dental treatment.
The purposes of this study were to (1) delineate the nature
and frequency of postdental treatment complications associ-
ated with dental treatment under IV sedation in individuals
with intellectual disability, and (2) correlate morbidity reports
with patient’s gender, age, and duration of dental procedures.2. Materials and methods
28 Patients with intellectual disability, 13 females and 15
males, aged 3–36 years, with a weight of range 10–80 kg,
healthy classiﬁed as ASA 1 or 11, were mainly referred from
the faculty of dentistry in Damascus University, Syria.
The patients were selected for IV sedation because they
were highly resistive during the initial examination. So each
patient previously exhibited combative behavior sufﬁcient
negative to dental treatment using routine behavior manage-
ment techniques. The research Ethics Committee of Damascus
University, Syria, approved the study. Informed consent was
obtained for the drug regimen. The parent was instructed to
keep the patient NPO for 8 h before the appointment, except
for a glass of water 4 h before the appointment. The parent
also was instructed to place a diaper on the patient. No
premedication was used.
The intellectual disability patients were treated at setting
room at maxillo-facial hospital at Faculty of dentistry,
Damascus University, Syria. The IV sedation was provided
by an anesthetist at the hospital. A certiﬁed registered nurse
anesthetist administered the drug and monitored the patient.
In this study, Propofol was given according to a previously
published guideline 1 mg/kg IV Propofol bolus Incremental
top ups of 0.25 mg/kg Propofol as required.
The protocol allowed for each patient to receive an addi-
tional intravenous bolus of Propofol. Sedation level was
adjusted to achieve scores of 5 on the Ramsay Sedation Scale
(Table 1).
All patients were treated by pediatric dentist residents
under direct supervision of pediatric dentist consultant. The
dental treatment started 5 min after Propofol administration,Table 1 Ramsay scale for the assessment of the level of
sedation.
Level of activity Points
Patient anxious agitated or restless 1
Patient cooperative, commentated and tranquil 2
Patient responding only to verbal commands 3
Patient with brisk response to light glabella
tap or loud auditory stimulus
4
Patient with sluggish response to light glabella
tap or loud auditory stimulus
5
Patient with no response to light glabella
tap or loud auditory stimulus
6when the patients were sufﬁciently sedated. No local anesthesia
had been performed. Sedation and treatment were satisfacto-
rily completed in all cases in one visit, and all patients involved
in this study were received the expected dental care. The most
frequent treatment was, extraction 82%, followed by ART
ﬁllings 11%. The least applied dental treatments were sealants
7%, requiring no saline irrigation. The treatment ended
between 9:30 AM and 1:00 PM. The duration of the treatment
was 5–60 min.
Vital signs consisting of blood pressure, respiratory rate,
heart rate and hemoglobin oxygen saturation via pulse oxime-
try were obtained. Resuscitation equipment was available if
required and a medical team followed each treatment session.
Preparing for discharge started in the recovery area. The
medical practitioner did not leave the recovery area until the
discharge criteria were met.
All patients involved in this study were observed in the
recovery room before the patient was ready to leave hospital
and postoperative complaints were recorded.
The presence or absence of posttreatment complications
including respiratory depression, cardiopulmonary complica-
tions, Bradycardia, emesis was evaluated. Also minor compli-
cations including, nausea, vomiting, sleepiness, pain, bleeding,
Agitation, and headache, and others such as coughing, were
evaluated by one pediatric dentist.
Discharge from recovery room was within 60 min. Patients
were discharged from the hospital after complete recovery,
which was deﬁned as the presence of vital variables within
reference limits, full wakefulness, and the ability to drink or
eat. The decision as to whether the patient was ready for
discharge was made by the resident in charge of the sedation.
2.1. Statistical analysis
The study included descriptive and analytical data. Complica-
tions while recovering in hospital were evaluated. The obtained
results were analyzed statistically using SSPS Version 13
statistical software. Statistical comparisons of patient compli-
cations, gender, age and duration of dental treatment were
made by unpaired Student’s t-test. All differences were
considered signiﬁcant at p< 0.05.
3. Results
No serious adverse effects occurred. There were no deaths and
no reported incidents of aspiration or emesis associated with
procedural Propofol sedation. None of the patients had
required mechanical ventilation.
Adverse events showed that 7 patients (25%) had less
serious posttreatment complications (Table 2).
The most common minor complaints reported were: Agita-
tion in 2 patients (28.6%), sleepiness in 2 patients (28.6%),
drowsiness in 1 patient (14.3%), and pain in 1 patient
(14.3%), followed by dental bleeding in 1 patient (14.3%)
(Table 3).
In this present study, statistical comparisons of patient
complications and gender were made by unpaired Student’s
t-test. A positive signiﬁcant correlation was found between
the presence of the complications and gender of the patient
(p value = 3.877, p= 0.049 < 0.05). This increase was greater
in males than in females (Table 4).
Table 2 Results of presence of one or more post-operative complication at recovery time.
No. patients Percentage
No complication One complication or more Total No complication One complication or more Total
21 7 28 75.0 25.0 100
Table 3 Results of post-operative complication at recovery
time.
Complication Number of patient Percentage (%)
Agitation 2 28.6
Sleepiness 2 28.6
Drowsiness 1 14.3
Pain 1 14.3
Dental bleeding 1 14.3
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complications, age and duration of dental treatment were
made by unpaired Student’s t-test. There were no signiﬁcant
differences found between the presence of the complications
and age of the patient (t= 1.306, p= 0.052 > 0.05) (Table 5),
and the duration of the treatment (t= 0.545, p= 0.591 > 0.05)
for the patient (Table 5).
4. Discussion
In this study intravenous sedation using Propofol was applied
for dental patients with intellectual disability similar to other
reports [4–6]. Propofol was given according to published
guideline [7,8] 1 mg/kg IV Propofol bolus Incremental topTable 5 Relationship between post-operative complaints and age o
No complication On
No. patients 21 7
Age of patient SMA 14.10 9.4
Standard deviation 9.19 2.9
Minimum 3 6
Ceiling 34 14
Student’s t-test 1.306
Duration of treatment SMA 22.25 19.
Standard deviation 11.75 13.
Minimum 5 10
Ceiling 60 45
Student’s t-test 0.545
Table 4 Relationship between post-operative complaints and gende
No. male
patients
No. female
patients
Total
Gender of patient No complication 9 12 21
One complication
or more
6 1 7
All 15 13 28ups of 0.25 mg/kg Propofol as required, as study of Newstead
and his colleagues [9]. A safe dosing regimen is therefore not
apparent, although started with a dose of 1 mg/kg followed
by titration of smaller doses to effect, as study of Symington
and Thakore [10].
Currently, there are no established deﬁnitions or
terminology for sedation-related adverse events (AEs). With
clear terminology and deﬁnitions, sedation events may be
accurately identiﬁed and tracked, providing a benchmark for
deﬁning the occurrence of AEs, ranging from minimal to
severe [11].
However, there was a paucity of data on the incidence of
complications performed with IV sedation for dental treat-
ment. This is the ﬁrst regional study to determine the type
and frequency of postoperative complaints expected of IV
Sedation for dental treatment in individuals with intellectual
disability.
In this study no immediate mortality was reported and no
serious adverse effects were seen, similar to some reports
[12–14], and similar to reports for intellectual disability
patients [1,6,15].
Trials suggest that the use of IV hydroxyethyl starch
solutions is associated with increased risk of death and acute
kidney injury in critically ill and surgical patients in the study
of Gillies and his colleagues [16].f the patient and duration of the treatment.
e complication or more
3
4
p 1.306 No signiﬁcant relationship
17
57
p 0.591 No signiﬁcant relationship
r of the patient.
Percentage
male patients
Percentage
female patients
Student’s
t-test
p
60.0 92.3 3.877 0.049 Signiﬁcant
relationship
40.0 7.7
100 100
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plications suffered by patients, similar to some reports using
IV Propofol sedation [13,17].
In this study no patient experienced respiratory depression
or required any intervention, in accordance with the study
performed by Phillips and his colleagues [16]. Hahl and his
colleagues observed that respiratory depression occurs mainly
during deep sedation in 19% of patients receiving Propofol
alone, due to deep sedation or over-dose sedation produced
by Propofol, but no associated morbidity or major adverse
events [18].
McGrane and his colleagues observed 4.65% experienced
adverse events related to procedural sedation with Propofol.
Hypotension was the most common, occurring in 2.33% of
the patients. 1.40% experienced brief hypoxia, 0.93% of
patients developed brief apnea that required brief bag valve
mask-assisted ventilation. No patient required any advanced
airway management [19].
In this study 1 h after treatment, minor complications
occurred in 7 (25%) of all performed IV sedation with Propofol
have been used, while the percentage was 10.1% in the study of
Lynette and his colleagues [20]. Adverse sedation events
occurred in 6.0%but there were no incidents with serious squeal
in the study of Ransford and his colleagues [21]. The sentinel
adverse event rate of 1% identiﬁed prompts review: 11 sentinel
(5 cases of hypoxia, 6 of hypotension), 34 moderate, 25 minor
and 3 minimal risk adverse events in the study of Newstead
and his colleagues [9]. In a previous study in adults with disabil-
ity using intranasal plus intravenous midazolam 6% of adverse
events were reported in the study of Manley and his colleagues
[22]. Also minor side effects were recorded for 16.6% of sessions
in patients with intellectual disability in the study of Callado
and his colleagues, using intravenousMidazolam. The disparity
between these results is in part due to differences in deﬁning and
recording minor adverse events [23].
In this study the most common complaint during early and
intermediate recovery reported was: Agitation 28.6%. This
phenomenon did not delay discharge from the recovery room.
In contrast, Picard and his colleagues reported Postoperative
agitation 9%.Also the use of Propofol is associated with a reduc-
tion in the incidence of emergence agitation in the study of Key
and his colleagues [24]. There were no instances of agitation,
nausea, or vomiting in the study of Lynette and his colleagues [20].
Other complaints included sleepiness were reported in this
study 28.6%. This would be expected given the time of the
day, since most of the treatment ended between 9:30 AM
and 1:00 PM, while the most common intraoperative and post-
adverse events were hallucination (3.9%) and excessive sleep
(41.9%), respectively in the study of Costa and his colleagues
using oral medication [25].
Postoperative pain was reported in this study 14.3%. In
other studies pain along the intravenous line after Propofol
injection was the most frequent adverse effect. It was reported
on injection in 48% (excluding patients with central venous
catheters), despite simultaneous lidocaine infusion in the study
of Barbi and his colleagues [26].
Shabana observed, the incidence of both immediate and
delayed types of pain associated with Propofol injection was
24% [27].
Postoperative dental bleeding was reported in this study
14.3%. It must be stated that all parents were given postoper-ative instructions that included patients eating soft foods,
staying well hydrate.
In this study there were no instances of postoperative
nausea and vomiting similar to other studies [3,20]. But the
incidence of both nausea and vomiting was signiﬁcantly lower
in the study of Moore and his colleagues [28].
Propofol has abronchodilating effect. Its anti-emetic character-
istic gives an added advantage to minimize postsedation nausea.
These aforementioned characteristics make propofol especially
beneﬁcial for individuals with intellectual disability [29].
In this study there was no cough reﬂex, but there was cough
reﬂex in the study of Kohjitani and his colleagues, for 21
intellectually disabled patients who were enrolled, coughing
episodes correlated neither with intraoral use of water nor with
infusion rate of Propofol. These ﬁndings suggested that accu-
mulation of water in the oropharynx increased vulnerability
to the cough reﬂex in dental treatments performed under intra-
venous sedation [30].
The incidence of cough episodes was signiﬁcantly higher
at the maxillary anterior site and lowest at the right man-
dibular molar areas in the study of Hanamoto and his
colleagues [31]. These ﬁndings suggest that difﬁculties in
swallowing and in the suction of intraoral ﬂuids have vari-
able effects at different surgical sites. Careful suction of
intraoral water and an appropriate sedation level are
required, especially in procedures in the maxillary anterior
region.
In this present study a positive signiﬁcant correlation was
found between the presence of the complications and gender
of the patient. This increase was greater in males than females.
This may be due to the slow rate of boy’s psychological matu-
ration that makes them unable to tolerate complications than
females. This difference found also by Norton and his
colleagues who investigate the hypnotic upper airway mechan-
ics during midazolam sedation and reported that men have
increased dynamic pressures required to induce upper airway
obstruction [32]. Female subjects required more negative
pressures to cause upper airway obstruction with midazolam
but not with Propofol. Also female sex hormone may play a
role in determining upper air way structures and mechanical
properties [33].
In this present study there were no signiﬁcant differences
found between the presence of the complications and age,
duration of dental treatment performed for the patient.
Age could not be stratiﬁed because the subjects recruited
were adults in the study of Rahman and Hashim [34], while
age and psychological maturity can affect emergence agitation
in the study of Picard and his colleagues [3]. Minor complica-
tions were recorded in children under 16 years, all patients
with intellectual disability in the study of Ransford and his
colleagues [21].
There was no signiﬁcant difference in the complications rate
between males and females, among the different ages, or
among the different indications for procedural sedation and
analgesia in the study of Pena and his colleagues [35].
This is the ﬁrst regional study to determine the postopera-
tive complications expected with IV sedation for dental treat-
ment in patients with intellectual disability. The strength of
this study came from its prospective design, which helped us
in determining the postoperative complications immediately
and did not allow for poor recall.
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to those patients. It should include large sample sizes from
varying disability kinds, and varying age will help strength
the results and provide greater conﬁdence when applying the
ﬁnding to clinical practice.5. Conclusion
The use of IV sedation with Propofol for patients with intellec-
tual disability for providing dental treatment appears to have
minor complications, when administered and monitored by a
qualiﬁed anesthetist.Conﬂict of interest
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